Phosphorylation, Glycosylation, and Proteolytic Activity of the 52-kD Estrogen-induced Protein Secreted by MCF7 Cells

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 1987 Feb 1

PMID 3543022

Citations 25

Authors

F Capony

M Morisset

A J Barrett

J P Capony

P Broquet

F Vignon

M Chambon

P Louisot

H ROCHEFORT

Affiliations

Soon will be listed here.

Abstract

We have studied the posttranslational modifications of the 52-kD protein, an estrogen-regulated autocrine mitogen secreted by several human breast cancer cells in culture (Westley, B., and H. Rochefort, 1980, Cell, 20:353-362). The secreted 52-kD protein was found to be phosphorylated mostly (94%) on high-mannose N-linked oligosaccharide chains, and mannose-6-phosphate signals were identified. The phosphate signal was totally removed by alkaline phosphatase hydrolysis. The secreted 52-kD protein was partly taken up by MCF7 cells via mannose-6-phosphate receptors and processed into 48- and 34-kD protein moieties as with lysosomal hydrolases. By electron microscopy, immunoperoxidase staining revealed most of the reactive proteins in lysosomes. After complete purification by immunoaffinity chromatography, we identified both the secreted 52-kD protein and its processed cellular forms as aspartic and acidic proteinases specifically inhibited by pepstatin. The 52-kD protease is secreted in breast cancer cells under its inactive proenzyme form, which can be autoactivated at acidic pH with a slight decrease of molecular mass. The enzyme of breast cancer cells, when compared with cathepsin D(s) of normal tissue, was found to be similar in molecular weight, enzymatic activities (inhibitors, substrates, specific activities), and immunoreactivity. However, the 52-kD protein and its cellular processed forms of breast cancer cells were totally sensitive to endo-beta-N-acetylglucosaminidase H (Endo H), whereas several cellular cathepsin D(s) of normal tissue were partially Endo H-resistant. This difference, in addition to others concerning tissue distribution, mitogenic activity and hormonal regulation, strongly suggests that the 52-kD cathepsin D-like enzyme of breast cancer cells is different from previously described cathepsin D(s). The 52-kD estrogen-induced lysosomal proteinase may have important functions in facilitating the mammary cancer cells to proliferate, migrate, and metastasize.

Citing Articles

Cathepsin D deficiency in mammary epithelium transiently stalls breast cancer by interference with mTORC1 signaling.

Ketterer S, Mitschke J, Ketscher A, Schlimpert M, Reichardt W, Baeuerle N Nat Commun. 2020; 11(1):5133.

PMID: 33046706 PMC: 7552405. DOI: 10.1038/s41467-020-18935-2.

Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages.

Jubrail J, Morris P, Bewley M, Stoneham S, Johnston S, Foster S Cell Microbiol. 2015; 18(1):80-96.

PMID: 26248337 PMC: 4778410. DOI: 10.1111/cmi.12485.

Procathepsin d involvement in chemoresistance of cancer cells.

Vetvicka V, Fusek M, Vashishta A N Am J Med Sci. 2012; 4(4):174-9.

PMID: 22536560 PMC: 3334257. DOI: 10.4103/1947-2714.94943.

Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.

Derocq D, Prebois C, Beaujouin M, Laurent-Matha V, Pattingre S, Smith G Oncogene. 2011; 31(26):3202-12.

PMID: 22081071 PMC: 3579766. DOI: 10.1038/onc.2011.501.

Expression patterns of ER, HER2, and NM23-H1 in breast cancer patients with different menopausal status: correlations with metastasis.

Dong S, Wang L, Sui J, Deng X, Chen X, Zhang Z Mol Diagn Ther. 2011; 15(4):211-9.

PMID: 21913743 DOI: 10.1007/BF03256412.

References

Hickman S, Neufeld E . A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem Biophys Res Commun. 1972; 49(4):992-9. DOI: 10.1016/0006-291x(72)90310-5. View

SOULE H, Vazguez J, Long A, Albert S, Brennan M . A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973; 51(5):1409-16. DOI: 10.1093/jnci/51.5.1409. View

Lippman M, Bolan G, Huff K . The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976; 36(12):4595-601. View

Carney D, Cunningham D . Role of specific cell surface receptors in thrombin-stimulated cell division. Cell. 1978; 15(4):1341-9. DOI: 10.1016/0092-8674(78)90059-4. View

Butler W, Kirkland W, Jorgensen T . Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7). Biochem Biophys Res Commun. 1979; 90(4):1328-34. DOI: 10.1016/0006-291x(79)91181-1. View

Westley B, ROCHEFORT H . A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 1980; 20(2):353-62. DOI: 10.1016/0092-8674(80)90621-2. View

Tabas I, Kornfeld S . Biosynthetic intermediates of beta-glucuronidase contain high mannose oligosaccharides with blocked phosphate residues. J Biol Chem. 1980; 255(14):6633-9. View

Sporn M, Todaro G . Autocrine secretion and malignant transformation of cells. N Engl J Med. 1980; 303(15):878-80. DOI: 10.1056/NEJM198010093031511. View

Mitrovic D, Gruson M, RYCKEWAERT A . Local hyperthermia and cartilage breakdown: histochemical and metabolic studies on rabbit articular cartilage in vitro. J Rheumatol. 1981; 8(2):193-203. View

10.

Puizdar V, Turk V . Cathepsinogen D: characterization and activation to cathepsin D and inhibitory peptides. FEBS Lett. 1981; 132(2):299-304. DOI: 10.1016/0014-5793(81)81184-2. View

11.

Hasilik A, von Figura K . Oligosaccharides in lysosomal enzymes. Distribution of high-mannose and complex oligosaccharides in cathepsin D and beta-hexosaminidase. Eur J Biochem. 1981; 121(1):125-9. DOI: 10.1111/j.1432-1033.1981.tb06440.x. View

12.

Broquet P, Leon M, Louisot P . Substrate specificity of cerebral GDP-fucose: glycoprotein fucosyltransferase. Eur J Biochem. 1982; 123(1):9-13. DOI: 10.1111/j.1432-1033.1982.tb06491.x. View

13.

Sahagian G, Gottesman M . The predominant secreted protein of transformed murine fibroblasts carries the lysosomal mannose 6-phosphate recognition marker. J Biol Chem. 1982; 257(18):11145-50. View

14.

Hasilik A, von Figura K, Conzelmann E, Nehrkorn H, Sandhoff K . Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. Eur J Biochem. 1982; 125(2):317-21. DOI: 10.1111/j.1432-1033.1982.tb06685.x. View

15.

Capony F, Garcia M, VEITH F, ROCHEFORT H . Antibodies to the estrogen induced 52 K protein released by human breast cancer cells. Biochem Biophys Res Commun. 1982; 108(1):8-15. DOI: 10.1016/0006-291x(82)91824-1. View

16.

Vignon F, Derocq D, Chambon M, ROCHEFORT H . [Estrogen-induced proteins secreted by MCF7 human breast cancer cells stimulate their proliferation]. C R Seances Acad Sci III. 1983; 296(3):151-6. View

17.

Bishop J . Cancer genes come of age. Cell. 1983; 32(4):1018-20. DOI: 10.1016/0092-8674(83)90284-2. View

18.

Capony J, Demaille J . A rapid microdetermination of phosphoserine, phosphothreonine, and phosphotyrosine in proteins by automatic cation exchange on a conventional amino acid analyzer. Anal Biochem. 1983; 128(1):206-12. DOI: 10.1016/0003-2697(83)90365-2. View

19.

Cooper J, Sefton B, Hunter T . Detection and quantification of phosphotyrosine in proteins. Methods Enzymol. 1983; 99:387-402. DOI: 10.1016/0076-6879(83)99075-4. View

20.

ROCHEFORT H, Chalbos D, Capony F, Garcia M, VEITH F, Vignon F . Effect of estrogen in breast cancer cells in culture: released proteins and control of cell proliferation. Prog Clin Biol Res. 1984; 142:37-51. View